U. J. Jung and M. Choi, Obesity and its metabolic complications: The role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease, Int. J. Mol. Sci, vol.15, pp.6184-6223, 2014.

Z. M. Younossi, A. B. Koenig, D. Abdelatif, Y. Fazel, L. Henry et al., Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes, Hepatology, vol.64, pp.73-84, 2016.

K. Yasutake, Dietary habits and behaviors associated with nonalcoholic fatty liver disease, World J. Gastroenterol, vol.20, 1756.

T. Hardy, F. Oakley, Q. M. Anstee, and C. P. Day, Nonalcoholic fatty liver disease: Pathogenesis and disease spectrum, Ann. Rev. Pathol, vol.11, pp.451-496, 2016.

A. M. Diehl and C. Day, Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis, N. Engl. J. Med, vol.377, pp.2063-2072, 2017.
DOI : 10.1056/nejmra1503519

S. H. Ibrahim, P. Hirsova, and G. J. Gores, Non-alcoholic steatohepatitis pathogenesis: Sublethal hepatocyte injury as a driver of liver inflammation, Gut, vol.67, pp.963-972, 2018.

E. Cobbina and F. Akhlaghi, Non-alcoholic fatty liver disease (NAFLD)-Pathogenesis, classification, and effect on drug metabolizing enzymes and transporters, Drug Metab. Rev, vol.49, pp.197-211, 2017.
DOI : 10.1080/03602532.2017.1293683

URL : http://europepmc.org/articles/pmc5576152?pdf=render

N. Bar?i´cbar?i´c, I. Leroti´cleroti´c, L. Smir?i´smir?i´c-duvnjak, V. Toma?i´ctoma?i´c, and M. Duvnjak, Overview and developments in noninvasive diagnosis of nonalcoholic fatty liver disease, World J. Gastroenterol, vol.18, pp.3945-3954, 2012.

N. Anderson and J. Borlak, Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis, Pharmacol. Rev, vol.60, pp.311-357, 2008.

E. Buzzetti, M. Pinzani, and E. A. Tsochatzis, The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD), Metab. Clin. Exp, vol.65, pp.1038-1048, 2016.

V. Patel and A. J. Sanyal, Drug-Induced Steatohepatitis, Clin. Liver Dis, vol.17, pp.533-546, 2013.

M. Noureddin and M. E. Rinella, Nonalcoholic fatty liver disease, diabetes, obesity, and hepatocellular carcinoma, Clin. Liver Dis, vol.19, pp.361-379, 2015.

T. Minato, M. Tsutsumi, M. Tsuchishima, N. Hayashi, T. Saito et al., Binge alcohol consumption aggravates oxidative stress and promotes pathogenesis of NASH from obesity-induced simple steatosis, Mol. Med, vol.20, pp.490-502, 2014.

Z. M. Younossi, Nonalcoholic fatty liver disease, Curr. Gastroenterol. Rep, vol.1, pp.57-62, 1999.

M. R. Teli, O. F. James, A. D. Burt, M. K. Bennett, and C. P. Day, The natural history of nonalcoholic fatty liver: A follow-up study, Hepatology, vol.22, pp.1714-1719, 1995.

J. J. Heindel, B. Blumberg, M. Cave, R. Machtinger, A. Mantovani et al., Metabolism disrupting chemicals and metabolic disorders, Reprod. Toxicol, vol.68, pp.3-33, 2017.

B. Wahlang, J. I. Beier, H. B. Clair, H. J. Bellis-jones, K. C. Falkner et al., Toxicant-associated steatohepatitis, Toxicol. Pathol, vol.41, pp.343-360, 2013.

, Biomolecules, vol.8, p.26, 2018.

S. Joshi-barve, I. Kirpich, M. C. Cave, L. S. Marsano, and C. J. Mcclain, Alcoholic, nonalcoholic, and toxicant-associated steatohepatitis: Mechanistic similarities and differences, Cell. Mol

, Gastroenterol. Hepatol, vol.1, pp.356-367, 2015.

C. E. Foulds, L. S. Treviño, B. York, and C. L. Walker, Endocrine-disrupting chemicals and fatty liver disease, Nat. Rev. Endocrinol, vol.13, pp.445-457, 2017.

F. Åberg, J. Helenius-hietala, P. Puukka, M. Färkkilä, and A. Jula, Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population, Hepatology, 2017.

A. M. Duly, B. Alani, E. Y. Huang, C. Yee, P. S. Haber et al., Effect of multiple binge alcohol on diet-induced liver injury in a mouse model of obesity, Nutr. Diabetes, vol.5, 2015.

S. Uno, D. W. Nebert, and M. Makishima, Cytochrome P450 1A1 (CYP1A1) protects against nonalcoholic fatty liver disease caused by Western diet containing benzo[a]pyrene in mice, Food Chem. Toxicol, vol.113, pp.73-82, 2018.

M. Robin, C. Demeilliers, A. Sutton, V. Paradis, C. Maisonneuve et al., Alcohol increases tumor necrosis factor alpha and decreases nuclear factor-kappab to activate hepatic apoptosis in genetically obese mice, Hepatology, vol.42, pp.1280-1290, 2005.

C. Duval, F. Teixeira-clerc, A. F. Leblanc, S. Touch, C. Emond et al., Chronic exposure to low doses of dioxin promotes liver fibrosis development in the c57bl/6j diet-induced obesity mouse model, vol.125, pp.428-436, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02196317

J. Massart, K. Begriche, C. Moreau, and B. Fromenty, Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity, J. Clin. Transl. Res, vol.3, pp.212-232, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01580159

K. Bambino, C. Zhang, C. Austin, C. Amarasiriwardena, M. Arora et al., Inorganic arsenic causes fatty liver and interacts with ethanol to cause alcoholic liver disease in zebrafish, Dis. Models Mech, vol.11, 2018.

S. Bucher, A. Tête, N. Podechard, M. Liamin, D. Le-guillou et al.,

Q. Ba, J. Li, C. Huang, H. Qiu, J. Li et al., Effects of benzo[a]pyrene exposure on human hepatocellular carcinoma cell angiogenesis, metastasis, and NF-?B signaling, Environ. Health Perspect, vol.123, pp.246-254, 2015.

P. W. Wester, J. J. Muller, W. Slob, G. R. Mohn, P. M. Dortant et al., Carcinogenic activity of benzo[a]pyrene in a 2 year oral study in Wistar rats, Food Chem. Toxicol, vol.50, pp.927-935, 2012.

K. Hardonnière, L. Huc, O. Sergent, J. A. Holme, and D. Lagadic-gossmann, Environmental carcinogenesis and pH homeostasis: Not only a matter of dysregulated metabolism, Semin. Cancer Biol, vol.43, pp.49-65, 2017.

X. Tekpli, J. A. Holme, O. Sergent, and D. Lagadic-gossmann, Role for membrane remodeling in cell death: Implication for health and disease, Toxicology, vol.304, pp.141-157, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00818916

X. Tekpli, J. A. Holme, O. Sergent, and D. Lagadic-gossmann, Importance of plasma membrane dynamics in chemical-induced carcinogenesis, Recent Pat. Anticancer Drug Discov, vol.6, pp.347-353, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00696148

N. Podechard, M. Chevanne, M. Fernier, A. Tête, A. Collin et al., Zebrafish larva as a reliable model for in vivo assessment of membrane remodeling involvement in the hepatotoxicity of chemical agents: Zebrafish larva for assessing membrane remodeling by hepatotoxicants, J. Appl. Toxicol, vol.37, pp.732-746, 2017.

A. Dolganiuc, Role of lipid rafts in liver health and disease, World J. Gastroenterol, vol.17, pp.2520-2535, 2011.

S. Inokuchi, H. Tsukamoto, E. Park, Z. Liu, D. A. Brenner et al., Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice, Alcohol. Clin. Exp. Res, vol.35, pp.1509-1518, 2011.

X. Tekpli, M. Rissel, L. Huc, D. Catheline, O. Sergent et al., Membrane remodeling, an early event in benzo[a]pyrene-induced apoptosis, Toxicol. Appl. Pharmacol, vol.243, pp.68-76, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00729575

X. Tekpli, L. Huc, O. Sergent, B. Dendelé, M. Dimanche-boitrel et al., NHE-1 relocation outside cholesterol-rich membrane microdomains is associated with its benzo[a]pyrene-related apoptotic function, Cell. Physiol. Biochem, vol.29, pp.657-666, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00871487

P. Nourissat, M. Travert, M. Chevanne, X. Tekpli, A. Rebillard et al., Ethanol induces oxidative stress in primary rat hepatocytes through the early involvement of lipid raft clustering, vol.47, pp.59-70, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00696177

Y. S. Roh, B. Zhang, R. Loomba, and E. Seki, TLR2 and TLR9 contribute to alcohol-mediated liver injury through induction of CXCL1 and neutrophil infiltration, Am. J. Physiol. Gastrointest. Liver Physiol, vol.309, pp.30-41, 2015.

A. Collin, K. Hardonnière, M. Chevanne, J. Vuillemin, N. Podechard et al., Cooperative interaction of benzo[a]pyrene and ethanol on plasma membrane remodeling is responsible for enhanced oxidative stress and cell death in primary rat hepatocytes. Free Radic, Biol. Med, vol.72, pp.11-22, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01018147

S. Das, F. Alhasson, D. Dattaroy, S. Pourhoseini, R. K. Seth et al., NADPH Oxidase-derived peroxynitrite drives inflammation in mice and human nonalcoholic steatohepatitis via tlr4-lipid raft recruitment, Am. J. Pathol, vol.185, pp.1944-1957, 2015.

K. Howe, M. D. Clark, C. F. Torroja, J. Torrance, C. Berthelot et al., The zebrafish reference genome sequence and its relationship to the human genome, Nature, vol.496, pp.498-503, 2013.

J. Chu and K. C. Sadler, New school in liver development: Lessons from zebrafish, Hepatology, vol.50, pp.1656-1663, 2009.

A. Schlegel, Studying non-alcoholic fatty liver disease with zebrafish: A confluence of optics, genetics, and physiology, Cell. Mol. Life Sci, vol.69, pp.3953-3961, 2012.

G. Forn-cuní, M. Varela, P. Pereiro, B. Novoa, and A. Figueras, Conserved gene regulation during acute inflammation between zebrafish and mammals, Sci. Rep, vol.7, p.41905, 2017.

W. Goessling and K. C. Sadler, Zebrafish: An Important Tool for Liver Disease Research, Gastroenterology, vol.149, pp.1361-1377, 2015.

M. J. Passeri, A. Cinaroglu, C. Gao, and K. C. Sadler, Hepatic steatosis in response to acute alcohol exposure in zebrafish requires sterol regulatory element binding protein activation, Hepatology, vol.49, pp.443-452, 2009.

W. Alderton, S. Berghmans, P. Butler, H. Chassaing, A. Fleming et al., Accumulation and metabolism of drugs and CYP probe substrates in zebrafish larvae, Xenobiotica, vol.40, pp.547-557, 2010.

B. Bugiak and L. P. Weber, Hepatic and vascular mRNA expression in adult zebrafish (Danio rerio) following exposure to benzo-a-pyrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin, Aquat. Toxicol, vol.95, pp.299-306, 2009.

S. Verstraelen, B. Peers, W. Maho, K. Hollanders, S. Remy et al., Phenotypic and biomarker evaluation of zebrafish larvae as an alternative model to predict mammalian hepatotoxicity, J. Appl. Toxicol, 2016.

M. Driessen, A. S. Kienhuis, J. L. Pennings, T. E. Pronk, E. Brandhof et al., Exploring the zebrafish embryo as an alternative model for the evaluation of liver toxicity by histopathology and expression profiling, Arch. Toxicol, vol.87, pp.807-823, 2013.

M. Driessen, A. S. Kienhuis, A. P. Vitins, J. L. Pennings, T. E. Pronk et al., Gene expression markers in the zebrafish embryo reflect a hepatotoxic response in animal models and humans, Toxicol. Lett, vol.230, pp.48-56, 2014.

M. Driessen, A. P. Vitins, J. L. Pennings, A. S. Kienhuis, B. Water et al., A transcriptomics-based hepatotoxicity comparison between the zebrafish embryo and established human and rodent in vitro and in vivo models using cyclosporine A, amiodarone and acetaminophen, Toxicol. Lett, vol.232, pp.403-412, 2015.

, Biomolecules, 2018.

O. Tsedensodnom, A. M. Vacaru, D. L. Howarth, C. Yin, and K. C. Sadler, Ethanol metabolism and oxidative stress are required for unfolded protein response activation and steatosis in zebrafish with alcoholic liver disease, Dis. Models Mech, vol.6, pp.1213-1226, 2013.

W. Dai, K. Wang, X. Zheng, X. Chen, W. Zhang et al., High fat plus high cholesterol diet lead to hepatic steatosis in zebrafish larvae: A novel model for screening anti-hepatic steatosis drugs, Nutr. Metab, vol.12, 2015.

C. Yan, Q. Yang, H. Shen, J. M. Spitsbergen, and Z. Gong, Chronically high level of tgfb1a induction causes both hepatocellular carcinoma and cholangiocarcinoma via a dominant Erk pathway in zebrafish, Oncotarget, vol.8, pp.77096-77109, 2017.

L. Cruz-garcia and A. Schlegel, Lxr-driven enterocyte lipid droplet formation delays transport of ingested lipids, J. Lipid Res, vol.55, pp.1944-1958, 2014.

A. A. Amali, R. D. Rekha, C. J. Lin, W. Wang, H. Gong et al., Thioacetamide induced liver damage in zebrafish embryo as a disease model for steatohepatitis, J. Biomed. Sci, vol.13, pp.225-232, 2006.

S. E. Hugo and A. Schlegel, A genetic screen for zebrafish mutants with hepatic steatosis identifies a locus required for larval growth, J. Anat, vol.230, pp.407-413, 2017.

, IARD (International Alliance for Responsible Drinking), 2018.

D. I. Walker, K. D. Pennell, K. Uppal, X. Xia, P. K. Hopke et al., Pilot Metabolome-Wide Association Study of Benzo(a)pyrene in Serum From Military Personnel, J. Occup. Environ. Med, vol.58, p.445, 2016.

N. Magee, A. Zou, and Y. Zhang, Pathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal Cells, BioMed Res. Int, pp.1-11, 2016.

D. Issa, V. Patel, and A. J. Sanyal, Future therapy for non-alcoholic fatty liver disease, Liver Int, vol.38, pp.56-63, 2018.

Y. Sumida and M. Yoneda, Current and future pharmacological therapies for NAFLD/NASH, J. Gastroenterol, vol.53, pp.362-376, 2018.

G. Shen and A. Kong, Nrf2 plays an important role in coordinated regulation of Phase II drug metabolism enzymes and Phase III drug transporters, Biopharm. Drug Dispos, vol.30, pp.345-355, 2009.

S. S. Chambel, A. Santos-gonçalves, and T. L. Duarte, The Dual Role of Nrf2 in Nonalcoholic Fatty Liver Disease: Regulation of Antioxidant Defenses and Hepatic Lipid Metabolism, Biomed. Res. Int, vol.597134, 2015.

D. M. Owen, C. Rentero, A. Magenau, A. Abu-siniyeh, and K. Gaus, Quantitative imaging of membrane lipid order in cells and organisms, Nat. Protoc, vol.7, pp.24-35, 2012.

E. Sezgin, T. Sadowski, and K. Simons, Measuring Lipid Packing of Model and Cellular Membranes with Environment Sensitive Probes, Langmuir, vol.30, pp.8160-8166, 2014.

M. Aron, R. Browning, D. Carugo, E. Sezgin, J. Bernardino-de-la-serna et al., Spectral imaging toolbox: Segmentation, hyperstack reconstruction, and batch processing of spectral images for the determination of cell and model membrane lipid order. BMC Bioinform, vol.18, 2017.

Y. Wei, X. Li, J. Xiong, J. M. Abais, M. Xia et al., Attenuation by statins of membrane raft-redox signaling in coronary arterial endothelium, J. Pharmacol. Exp. Ther, vol.345, pp.170-179, 2013.

K. Hardonnière, M. Fernier, I. Gallais, B. Mograbi, N. Podechard et al.,

K. Sugimoto and Y. Takei, Pathogenesis of alcoholic liver disease: Pathogenesis of alcoholic liver disease, Hepatol. Res, vol.47, pp.70-79, 2017.

T. Souza, D. Jennen, J. Van-delft, M. Van-herwijnen, S. Kyrtoupolos et al., New insights into BaP-induced toxicity: Role of major metabolites in transcriptomics and contribution to hepatocarcinogenesis, Arch. Toxicol, vol.90, pp.1449-1458, 2016.

, Biomolecules, 2018.

K. Hardonnière, E. Saunier, A. Lemarié, M. Fernier, I. Gallais et al., The environmental carcinogen benzo[a]pyrene induces a Warburg-like metabolic reprogramming dependent on NHE1 and associated with cell survival, Sci. Rep, vol.6, 2016.

J. Liu, Z. Zhuang, D. Bian, X. Ma, Y. Xun et al., Toll-like receptor-4 signalling in the progression of non-alcoholic fatty liver disease induced by high-fat and high-fructose diet in mice, Clin. Exp. Pharmacol. Physiol, vol.41, pp.482-488, 2014.

A. G. Sutter, A. P. Palanisamy, J. H. Lench, S. Esckilsen, T. Geng et al., Dietary Saturated Fat Promotes Development of Hepatic Inflammation Through Toll-Like Receptor 4 in Mice, J. Cell. Biochem, vol.117, pp.1613-1621, 2016.

M. A. Gianfrancesco, N. Paquot, J. Piette, and S. Legrand-poels, Lipid bilayer stress in obesity-linked inflammatory and metabolic disorders, Biochem. Pharmacol, 2018.

Y. S. Roh and E. Seki, Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis, J. Gastroenterol. Hepatol, vol.28, pp.38-42, 2013.

C. Decaens, P. Rodriguez, C. Bouchaud, and D. Cassio, Establishment of hepatic cell polarity in the rat hepatoma-human fibroblast hybrid WIF-B9. A biphasic phenomenon going from a simple epithelial polarized phenotype to an hepatic polarized one, J. Cell Sci, vol.109, pp.1623-1635, 1996.

C. Biagini, V. Bender, F. Borde, E. Boissel, M. Bonnet et al., Cytochrome P450 expression-induction profile and chemically mediated alterations of the WIF-B9 cell line, Biol. Cell, vol.98, pp.23-32, 2006.

B. L. Mcvicker, D. J. Tuma, J. L. Kubik, P. L. Tuma, and C. A. Casey, Ethanol-induced apoptosis in polarized hepatic cells possibly through regulation of the Fas pathway, Alcohol. Clin. Exp. Res, vol.30, 1906.

J. Ozeki, S. Uno, M. Ogura, M. Choi, T. Maeda et al., Aryl hydrocarbon receptor ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin enhances liver damage in bile duct-ligated mice, Toxicology, vol.280, pp.10-17, 2011.

C. S. Lieber, Alcoholic fatty liver: Its pathogenesis and mechanism of progression to inflammation and fibrosis, Alcohol, vol.34, pp.9-19, 2004.

J. Liu, K. C. Wu, Y. Lu, E. Ekuase, and C. D. Klaassen, NRF2 Protection against Liver Injury Produced by Various Hepatotoxicants, Oxid. Med. Cell. Longev, pp.1-8, 2013.

K. C. Wu, J. Y. Cui, and C. D. Klaassen, Effect of Graded Nrf2 Activation on Phase-I and-II Drug Metabolizing Enzymes and Transporters in Mouse Liver, PLoS ONE, vol.7, 2012.

I. M. Copple, A. T. Dinkova-kostova, T. W. Kensler, K. T. Liby, and W. Wigley, NRF2 as an Emerging Therapeutic Target, Oxid. Med. Cell. Longev, pp.1-2, 2017.

B. D. Henriksbo and J. Schertzer, Is immunity a mechanism contributing to statin-induced diabetes? Adipocyte, vol.4, pp.232-238, 2015.

W. Wu, L. Zhao, P. Yang, W. Zhou, B. Li et al., Inflammatory Stress Sensitizes the Liver to Atorvastatin-Induced Injury in ApoE-/-Mice, PLoS ONE, vol.11, 2016.

D. Pastori, L. Polimeni, F. Baratta, A. Pani, M. Del-ben et al., The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease. Dig. Liver Dis, vol.47, pp.4-11, 2015.

H. Park, J. E. Jang, M. S. Ko, S. H. Woo, B. J. Kim et al., Statins Increase Mitochondrial and Peroxisomal Fatty Acid Oxidation in the Liver and Prevent Non-Alcoholic Steatohepatitis in Mice, Diabetes Metab. J, vol.40, 2016.

K. Kim, H. Jang, Y. R. Yang, K. Park, J. Seo et al., SREBP-2/PNPLA8 axis improves non-alcoholic fatty liver disease through activation of autophagy

W. Wang, C. Zhao, J. Zhou, Z. Zhen, Y. Wang et al., Simvastatin Ameliorates Liver Fibrosis via Mediating Nitric Oxide Synthase in Rats with Non-Alcoholic Steatohepatitis-Related Liver Fibrosis, PLoS ONE, vol.8, 2013.

H. Hyogo, S. Yamagishi, S. Maeda, Y. Kimura, T. Ishitobi et al., Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-?-lowering property. Dig. Liver Dis, vol.44, pp.492-496, 2012.

, Biomolecules, vol.8, 2018.

W. Samy and M. A. Hassanian, Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin, Arab J. Gastroenterol, vol.12, pp.80-85, 2011.

K. Orime, J. Shirakawa, Y. Togashi, K. Tajima, H. Inoue et al., Lipid-lowering agents inhibit hepatic steatosis in a non-alcoholic steatohepatitis-derived hepatocellular carcinoma mouse model, Eur. J. Pharmacol, vol.772, pp.22-32, 2016.

K. Tziomalos, V. G. Athyros, P. Paschos, and A. Karagiannis, Nonalcoholic fatty liver disease and statins, Metab. Clin. Exp, vol.64, pp.1215-1223, 2015.

Y. Okada, K. Yamaguchi, T. Nakajima, T. Nishikawa, M. Jo et al., Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats, Liver Int, vol.33, pp.301-311, 2013.

G. Musso, M. Cassader, and R. Gambino, Cholesterol-lowering therapy for the treatment of nonalcoholic fatty liver disease: An update, Curr. Opin. Lipidol, vol.22, pp.489-496, 2011.

G. Ji, X. Zhao, L. Leng, P. Liu, and Z. Jiang, Comparison of Dietary Control and Atorvastatin on High Fat Diet Induced Hepatic Steatosis and Hyperlipidemia in Rats, Lipids Health Dis, vol.10, 2011.

J. P. Otis and S. A. Farber, High-fat Feeding Paradigm for Larval Zebrafish: Feeding, Live Imaging, and Quantification of Food Intake, J. Vis. Exp, vol.116, 2016.

E. Marza, C. Barthe, M. André, L. Villeneuve, C. Hélou et al., Developmental expression and nutritional regulation of a zebrafish gene homologous to mammalian microsomal triglyceride transfer protein large subunit: Regulation of mtp Expression in Zebrafish, Dev. Dyn, vol.232, pp.506-518, 2005.

A. Tingaud-sequeira, N. Ouadah, and P. J. Babin, Zebrafish obesogenic test: A tool for screening molecules that target adiposity, J. Lipid Res, vol.52, pp.1765-1772, 2011.

J. Schindelin, I. Arganda-carreras, E. Frise, V. Kaynig, M. Longair et al., An open-source platform for biological-image analysis, Nat. Methods, vol.9, pp.676-682, 2012.

E. De-lara-rodrigues and E. Fanta, Liver histopathology of the fish Brachydanio rerio hamilton-buchman after acute exposure to sublethal levels of the organophosphate dimethoate 500, Rev. Bras. Zool, vol.15, pp.441-450, 1998.

S. Caldwell, Y. Ikura, D. Dias, K. Isomoto, A. Yabu et al., Hepatocellular ballooning in NASH, J. Hepatol, vol.53, pp.719-723, 2010.
DOI : 10.1016/j.jhep.2010.04.031

URL : http://europepmc.org/articles/pmc2930100?pdf=render